Literature DB >> 9441747

The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization.

W Korver1, J Roose, K Heinen, D O Weghuis, D de Bruijn, A G van Kessel, H Clevers.   

Abstract

We recently identified the winged-helix/fork head transcription factor Trident in mouse and described its expression in cycling cells. Here we report the isolation and characterization of the human TRIDENT (HGMW-approved symbol FKHL16) cDNA and gene. Homology between the human and the mouse Trident proteins was 79%. The gene consists of 10 exons and is located on chromosome 12 band p13. The winged-helix DNA-binding domain is encoded on three exons. Analysis of the promoter in synchronized Rat-1 fibroblasts revealed a fragment of 300 bases responsible for the cell cycle-specific expression of the TRIDENT gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441747     DOI: 10.1006/geno.1997.5065

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  41 in total

1.  Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin.

Authors:  Vladimir Petrovic; Robert H Costa; Lester F Lau; Pradip Raychaudhuri; Angela L Tyner
Journal:  Cancer Biol Ther       Date:  2010-06-06       Impact factor: 4.742

Review 2.  In control of biology: of mice, men and Foxes.

Authors:  Patrick J E C Wijchers; J Peter H Burbach; Marten P Smidt
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

Review 3.  FoxM1: a novel tumor biomarker of lung cancer.

Authors:  Jia Zhang; Jing Zhang; Xiaohai Cui; Ya Yang; Min Li; Jingkun Qu; Junhai Li; Jiansheng Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription.

Authors:  Wei-Dong Chen; Yan-Dong Wang; Lisheng Zhang; Steven Shiah; Meihua Wang; Fan Yang; Donna Yu; Barry M Forman; Wendong Huang
Journal:  Hepatology       Date:  2010-03       Impact factor: 17.425

Review 5.  Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy.

Authors:  Min Shi; Jiujie Cui; Keping Xie
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

6.  FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.

Authors:  Richard E Francis; Stephen S Myatt; Janna Krol; Johan Hartman; Barrie Peck; Ursula B McGovern; Jun Wang; Stephanie K Guest; Aleksandra Filipovic; Ondrej Gojis; Carlo Palmieri; David Peston; Sami Shousha; Qunyan Yu; Piotr Sicinski; R Charles Coombes; Eric W-F Lam
Journal:  Int J Oncol       Date:  2009-07       Impact factor: 5.650

7.  FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.

Authors:  J Millour; D Constantinidou; A V Stavropoulou; M S C Wilson; S S Myatt; J M-M Kwok; K Sivanandan; R C Coombes; R H Medema; J Hartman; A E Lykkesfeldt; E W-F Lam
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

Review 8.  FOX(M1) news--it is cancer.

Authors:  Marianna Halasi; Andrei L Gartel
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

9.  Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression.

Authors:  Qiang Li; Nu Zhang; Zhiliang Jia; Xiangdong Le; Bingbing Dai; Daoyan Wei; Suyun Huang; Dongfeng Tan; Keping Xie
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

10.  Gestational diabetes mellitus resulting from impaired beta-cell compensation in the absence of FoxM1, a novel downstream effector of placental lactogen.

Authors:  Hongjie Zhang; Jia Zhang; Christine F Pope; Laura A Crawford; Rupangi C Vasavada; Shubhada M Jagasia; Maureen Gannon
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.